Bottom line
TRGGX vs SMCFX: the short answer
TRGGX (Goldman Sachs Tax-Advantaged Global Equity Portfolio) and SMCFX (Smallcap World Fund Inc) are both mutual funds.
But SMCFX is far broader, holding 862 positions to 69 for TRGGX, so beyond the top names it adds exposure TRGGX doesn't have.
SMCFX is cheaper at 0.76% vs 0.85% — a difference of $9.00 a year per $10,000 invested.
Over five years, TRGGX returned +10.7% a year vs +5.5% for SMCFX.
Updated Nov 19, 2026
TRGGX vs SMCFX side by side
| TRGGX | SMCFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Goldman Sachs | American Funds (Capital Group) |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.85% | 0.76% |
| Annual cost per $10k | $85 | $76 |
| 10-yr cost on $10k (prospectus) | $1,074 | $942 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +18.8% | +2.6% |
| 5-yr return (annualized) | +10.7% | +5.5% |
| 10-yr return (annualized) | +8.8% | +8.0% |
| Best quarter | — | +31.9% |
| Worst quarter | — | −22.5% |
| Net assets (fund) | $6.0B | $94.6B |
| Number of holdings | 69 | 862 |
| Portfolio turnover | 28% | 41% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
TRGGX and SMCFX share none of their top holdings.
TRGGX top 10
- Goldman Sachs Trust — 69.69%
- Goldman Sachs Trust — 11.28%
- Goldman Sachs Trust — 6.97%
- Goldman Sachs Trust — 6.54%
- Goldman Sachs Trust — 1.96%
- Ishares Trust — 0.99%
- Select Sector Spdr Trust (the) — 0.37%
- Ishares Inc — 0.10%
- Sprott Physical Uranium Trust — 0.08%
- Morgan Stanley & Co. Llc — 0.04%
SMCFX top 10
- Capital Group Central Cash Fund — 2.65%
- Kokusai Electric Corp — 1.37%
- Mks Inc — 1.15%
- Diploma Plc — 1.04%
- Comfort Systems USA Inc — 0.93%
- Ati Inc — 0.88%
- Global Unichip Corp — 0.76%
- Lumentum Holdings Inc — 0.74%
- Crane Co — 0.72%
- Asmpt Ltd — 0.70%
FAQ
What is the difference between TRGGX and SMCFX?
Which is cheaper, TRGGX or SMCFX?
Should I own both TRGGX and SMCFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.